研究HLA-DQ2/8与腹腔疾病的关联,并识别代理SNP来预测它们在北印度人口中的存在
Priyanka Tiwari1, B K Thelma2, Ajit Sood3
1Immunogenomics Laboratory, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India.
International journal of immunogenetics
|March 9, 2026
概括
北印度的乳风险与HLA-DQ2.5密切相关,而HLA-DQ8似乎具有保护作用. 特定的遗传标记现在可以有效地预测这种风险.
科学领域:
- 免疫遗传学 免疫遗传学
- 胃肠病学 胃肠病学
- 人口遗传学 人口遗传学
背景情况:
- 病 (CD) 的患病率在全球范围内有所不同,印度北部的患病率很高.
- 人类白细胞抗原 (HLA) -DQ2和-DQ8是已知的CD风险因素,但它们在北印度的特定关联需要进一步调查.
- 关于HLA-DQ等位基因频率及其与北印度人口中CD相关性的数据有限.
研究的目的:
- 确定HLA-DQ2和HLA-DQ8等位基因与北印度队列中乳病的频率和关联.
- 为了确定与CD表型相关的特定HLA-DQ基因型.
- 发现可靠的代理单核酸多态 (SNPs) 用于预测HLA-DQ基因型.
主要方法:
- 病例控制研究涉及459名CD患者和450名来自北印度的对照.
- 使用SSP-PCR对已知的CD相关HLA-DQ等位基因 (HLA-DQA1*05:01/02:01/03:01和HLA-DQB1*02/*03:02) 进行基因定型.
- 对现有的密集Illumina_Immunochip数据进行分析,以确定HLA-DQ基因型的代理SNP.
主要成果:
- 在CD患者中,99%的患者携带HLA-DQ2.5,DQ2.2或DQ8.
- HLA-DQA1*05:01和HLA-DQB1*02是最强的敏感性等位基因.
- HLA-DQ2.5显示出与CD的高度关联 (OR = 29.01),而DQ8显示出保护作用 (OR = 0.42).
- 特定的基因型 (HLA-DQ2.5/8和HLA-DQ2.5/2.2) 与血清抗tTG-IgA和皮肤疾病相关.
- 三个代理SNP (rs1129740,rs9273012,rs7744001) 已被确定用于预测HLA-DQ基因型.
结论:
- 在北印度,HLA-DQ2.5与乳风险密切相关,而DQ8似乎具有保护作用.
- 已识别的代理SNP提供了一种具有成本效益的方法来评估该群体的CD风险.
- 这项研究提供了对北印度乳病遗传情景的关键见解.
相关概念视频
Genome-wide Association Studies-GWAS
16.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.3K
Pharmacogenomics: Identification of New Drug Targets
57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57
Single Nucleotide Polymorphisms-SNPs
19.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.2K


